NSIX -- Neuromedical Systems, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NSIX -- Neuromedical Systems, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: TLWatson59 who wrote (125)	1/6/1999 9:12:00 AM
From: TLWatson59	Read Replies (1) of 137

Latest News release sounds like they've lost their way: Wednesday January 6, 7:30 am Eastern Time Company Press Release SOURCE: Neuromedical Systems, Inc. NSI Announces Engagement of Houlihan Lokey as Financial Advisor UPPER SADDLE RIVER, N.J., Jan. 6 /PRNewswire/ -- Neuromedical Systems, Inc. (NSI) (Nasdaq: NSIX - news) announced that it has engaged Houlihan Lokey Howard & Zukin as financial advisor to the Company. Houlihan Lokey has been retained to assist the Company in identifying and evaluating its strategic alternatives. ''We are excited about Houlihan Lokey joining our team. This is an important step in our continuing efforts to maximize the value of the PapNet® technology,'' said Paul R. Sohmer, M.D., President and CEO of NSI. Neuromedical Systems, Inc. focuses intelligent vision on medicine. Neuromedical's first product, the PapNet® Testing System, increases the accuracy of cervical screening by displaying potentially abnormal cells for review and analysis by a cytology professional. The Company believes that increasing access to routine screening and the adoption of PapNet testing can reduce the morbidity and mortality associated with cervical cancer.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next